← brief for 2026-08-14 · Slowing decline

Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World Data

Paper B Peer reviewed Small trial

Key takeaways

This study used real-world data from Japan to see if SGLT2i drugs are safe for people aged 80 and older. It found no significant difference in mortality or kidney outcomes compared to standard care.

Who did this work

Willerding JM · Melk A · Schmidt-Ott K · Greite R · Gwinner W · Doricic J · Schmidt BMW

Source

Paper · Europe PMC, CKD · 2026-08-12
https://doi.org/10.64898/2026.08.11.26360158